UNSPSC 51293017: Protriptyline hydrochloride

This classification denotes a tricyclic antidepressant with the molecular formula C19H21N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 44665V00O8, chemically known as 7-(3-methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene but more generally known as protriptyline hydrochloride, which bears US NIH Compound Identifier 4976. European Medicines Agency schedules Protriptyline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04117MIG.

Most nations, for tariff and trade purposes, schedule protriptyline hydrochloride under HS 29214980 and SITC 51454. As of Q4 2014, PROTRIPTYLINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Protriptyline hydrochloride bears US NLM identifiers UMLS ID C0042910 and NCI Concept Code C47695. SMILES: CNCCCC1C2CCCCC2C=CC3C1CCCC3.CL.

UNSPSC 51293017 Protriptyline hydrochloride is a Commodity code for a specific tricyclic antidepressant pharmaceutical, but the recent state and local activity tagged under this code does not reflect purchases of the drug itself. Instead, Seminole County, Florida's recent IFB solicitation targets naloxone (an opioid antagonist) and safe drug deactivation systems—products unrelated to protriptyline's therapeutic scope. This mismatch suggests either a tagging error in the county's procurement system or a data classification inconsistency. State and local buyers posting under pharmaceutical commodity codes typically include public health departments, county health agencies, correctional facilities, and emergency management authorities seeking specific drugs or drug-related services for community health programs. The recent Seminole County opportunity reflects public-health-focused procurement for overdose response and controlled-substance management.

Seminole County, Florida is the sole source of recent documented activity under this code. The county issued IFB 60459723LAS on June 30, 2026, seeking annual delivery of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly shipments to the Seminole County Community Health Building in Sanford, with a response deadline of July 26, 2023. The contract carries a two-year initial term with a one-year renewal option, fixed pricing, and E-Verify compliance requirements; FEMA funding may apply, introducing additional federal regulatory compliance. Because the solicitation is plainly misaligned with protriptyline hydrochloride procurement, this code shows no substantive recent activity in state and local pharmaceutical acquisition for its stated commodity.